Earthworm, a novel in vivo system to validate antimitotic compounds

Earthworm, a novel in vivo system to validate antimitotic compounds

We report here that earthworm can be used as an in vivo system to prescreen antimitotic compounds. The known antimitoticcompound colchicine and the aqueous extract of Acorus calamus L. rhizome were used to examine this system. The antimitoticactivity of colchicine and the rhizome extract was confirmed by methods with Allium cepa root tip, earthworm regeneration, andMTT (3-(4,5-dimethyl thiazolyl-2-yl)-2,5-diphenyltetrazolium bromide). An earthworm regeneration assay examined the regenerationability of tissues from amputated regions of the earthworm. All 3 assays showed that cell division is inhibited with colchicine and theaqueous extract of A. calamus rhizome. Histology studies with amputated earthworms confirmed that the development of the blastemawas observed only in control worms. Immunohistochemistry analysis with proliferation cell nuclear antigen and phospho serine 10histone H3 antibodies showed that amputated worms treated with colchicine or the aqueous extract of A. calamus did not have activecell division. MTT assay with the MCF-7 cell line (human breast carcinoma) further confirmed that the aqueous extract of rhizomeaffected cell proliferation. Our results suggest that the earthworm could be used to prescreen the antimitotic potential of plant extractsor other unknown compounds. It is simple, reproducible, and cost-efficient compared to animal cell line-based methods.

___

  • Baldo BA, Pham NH (2013). Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure–Activity Relationships. New York, NY, USA: Springer.
  • Bhattacharyya B, Panda D, Gupta S, Banerjee M (2008). Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med Res Rev 28: 155-183.
  • Cella D, Peterman A, Hudgens S, Webster K, Socinski MA (2003). Measuring the side effects of taxane therapy in oncology. Cancer 98: 822-831.
  • Coker PS, Radecke J, Guy C, Camper ND (2003). Potato disc tumor induction assay: a multiple mode of drug action assay. Phytomedicine 10: 133-138.
  • Denizot F, Lang R (1986). Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277.
  • Doke SK, Dhawale SC (2015). Alternatives to animal testing: a review. Saudi Pharm J 23: 223-229.
  • Eigsti OJ (1939). A cytological study of colchicine effects in the induction of polyploidy in plants. Protoplasma 32: 318-318.
  • Fadeyi SA, Fadeyi OO, Adejumo AA, Okoro C, Myles El (2013). In vitro anticancer screening of 24 locally used Nigerian medicinal plants. BMC Complement Altern Med 13: 79.
  • Festing S, Wilkinson R (2007). The ethics of animal research: talking point on the use of animals in scientific research. EMBO Rep 8: 526-530.
  • Foley JF, Dietrich DR, Swenberg JA Maronpot RR (1991). Detection and evaluation of proliferating cell nuclear antigen (PCNA) in rat tissue by an improved immunohistochemical procedure. J Histotechnol 14: 237-241.
  • Fouché G, Cragg GM, Pillay P, Kolesnikova N, Maharaj VJ Senabe J (2008). In vitro anticancer screening of South African plants. J Ethnopharmacol 119: 455-461.
  • Gascoigne KE, Taylor SS (2009). How do anti-mitotic drugs kill cancer cells? J Cell Sci 122: 2579-2585.
  • Imam H, Riaz Z, Azhar M, Sofi G, Hussain A (2013). Sweet flag (Acorus calamus Linn.): an incredible medicinal herb. Int J Green Pharm 7: 288.
  • Jordan MA, Wilson L (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253.
  • Kalidas RM, Raja SE, Mydeen SAKNM, Samuel SCJR, Durairaj SCJ, Nino GD, Palanichelvam K, Vaithi A, Sudhakar S (2015). Conserved lamin A protein expression in differentiated cells in the earthworm Eudrilus eugeniae. Cell Biol Int 39: 1036-1043.
  • Khazir J, Mir BA, Pilcher L, Riley DL (2014). Role of plants in anticancer drug discovery. Phytochem Lett 7: 173-181.
  • Kundu LM, Ray S (2017). Mitotic abnormalities and micronuclei inducing potentials of colchicine and leaf aqueous extracts of Clerodendrum viscosum Vent. in Allium cepa root apical meristem cells. Caryologia 70: 7-14.
  • Levan A (1938). The effect of colchicine on root mitoses in Allium. Hereditas 24: 471-486.
  • Li Y, Huang W, Huang S, Du J, Huang C (2012). Screening of anticancer agent using zebrafish: comparison with the MTT assay. Biochem Biophys Res Commun 422: 85-90.
  • Mukhtar E, Adhami VM, Mukhtar H (2014). Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther 13: 275- 284.
  • Murthy GS, Francis TP, Singh CR, Nagendra HG, Naik C (2011). An assay for screening anti-mitotic activity of herbal extracts. Curr Sci 100: 1399-1404.
  • Pan L, Chai H, Kinghorn AD (2010). The continuing search for antitumor agents from higher plants. Phytochem Lett 3: 1-8.
  • Rajkumar V, Gunjan G, Ashok Kumar R, Lazar M (2009). Evaluation of cytotoxic potential of Acorus calamus rhizome. Ethnobot Leaflets 13: 832-839.
  • Ryan JA (1994). Understanding and Managing Cell Culture Contamination. New York, NY, USA: Corning Incorporated.
  • Samuel SCJR, Elaiya Raja S, Beryl Vedha Y, Edith Arul Jane A, Amutha K, Dinesh SM, Jackson Durairaj SC, Kalidas RM, Tharmaraj V, Pitchumani K et al. (2011). Autofluorescence in BrdU-positive cells and augmentation of regeneration kinetics by riboflavin. Stem Cells Dev 21: 2071-2083.
  • Santos‐Ruiz L, Santamaría JA, Ruiz‐Sánchez J, Becerra J (2002). Cell proliferation during blastema formation in the regenerating teleost fin. Dev Dyn 223: 262-272.
  • Semenova MN, Kiselyov AS, Tsyganov DV, Konyushkin LD, Firgang SI, Semenov RV, Malyshev OR, Raihstat MM, Fuchs F, Stielow A et al. (2011). Polyalkoxybenzenes from plants. 5. Parsley seed extract in synthesis of Azapodophyllotoxins featuring strong tubulin destabilizing activity in the sea urchin embryo and cell culture assays. J Med Chem 54: 7138-7149.
  • Shailajan S, Menon S, Swar G, Singh D, Nair S (2015). Estimation and quantitation of β-asarone from Acorus calamus rhizome and its formulations using validated RP-HPLC method. Pharm Methods 6: 94-99.
  • Sreejaya SB, Santhy KS (2013). Cytotoxic properties of Acorus calamus in MCF-7 breast cancer cells. Int J Curr Res Acad Rev 1: 106-111.
  • Subramanian ER, Daisy NG, Sudalaimani DK, Ramamoorthy K, Balakrishnan S, Christyraj JDS, Arumugaswami V, Sivasubramaniam S (2017). Function of translationally controlled tumor protein (TCTP) in Eudrilus eugeniae regeneration. PLoS One 12: e0175319.
  • Tannous BA, Kerami M, Van der Stoop PM, Kwiatkowski N, Wang J, Zhou W, Kessler AF, Lewandrowski G, Hiddingh L, Sol N et al. (2013). Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. JNCI-J Natl Cancer I 105: 1322-1331.
  • Van Vuuren RJ, Visagie MH, Theron AE, Joubert AM (2015). Antimitotic drugs in the treatment of cancer. Cancer Chemother Pharmac 76: 1101-1112.
  • Ved CH, More NS, Bharate SS, Bharate SB (2010). Cytotoxicity screening of selected Indian medicinal plants using brineshrimp lethality bioassay. Adv Nat Appl Sci 4: 389-396.
  • Weaver BA (2014). How Taxol/paclitaxel kills cancer cells. Mol Biol Cell 25: 2677-2681.
  • Wu J, Zhang XX, Sun QM, Chen M, Liu S L, Zhang X, Zhou JY, Zou X (2015). β-Asarone inhibits gastric cancer cell proliferation. Oncol Rep 34: 3043-3050.